BAMAQUIMAST

Details

Stereochemistry	ACHIRAL
Molecular Formula	C16H21N3O3
Molecular Weight	303.3562
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CCCN1C(=O)C(CCCOC(=O)NC)=NC2=C1C=CC=C2

InChI

InChIKey=HNQSZPBGDAJIJO-UHFFFAOYSA-N

InChI=1S/C16H21N3O3/c1-3-10-19-14-9-5-4-7-12(14)18-13(15(19)20)8-6-11-22-16(21)17-2/h4-5,7,9H,3,6,8,10-11H2,1-2H3,(H,17,21)

HIDE SMILES / InChI

Molecular Formula	C16H21N3O3
Molecular Weight	303.3562
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: https://adisinsight.springer.com/drugs/800006975

Bamaquimast was developed by Pierre Fabre as an inhibitor of the proton pump with anti-inflammatory and anti-asthmatic effects. This drug participated in phase II clinical trials for the treatment of patients with asthma. However, these studies were discontinued.

Originator

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Proton pump 1 Target ID: Proton pump Sources: https://www.medchemexpress.com/Bamaquimast.html	Inhibitor 8504

Substance Class	Chemical Created by `admin` on `Mon Mar 31 17:58:39 GMT 2025` Edited by `admin` on `Mon Mar 31 17:58:39 GMT 2025`
Record UNII	5MZ70CT96H
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

3-(3-HYDROXYPROPYL)-1-PROPYL-2(1H)-QUINOXALINONE METHYLCARBAMATE (ESTER)

Preferred Name

English

BAMAQUIMAST

Official Name

English

bamaquimast [INN]

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C29712